硬皮病是一种可以持续数月至数年的疾病。
Scleroderma is a chronic disease that lasts many months to years.
然而，存在硬皮病遗传因素的日益增长的证据。
However, there is increasingly strong evidence of a genetic predisposition to scleroderma.
患者诊断为硬化萎缩性苔藓合并局限性硬皮病。
The case was diagnosed as lichen sclerosus et atrophicus with localized scleroderma .
局限性硬皮病发病可能与自身免疫性因素有关。
Localized scleroderma may be associated with some autoimmune-related causes.
目的研究五痹胶囊治疗系统性硬皮病的药理作用。
Objective To study the pharmacological action of Wubi capsule on sclerosis.
在我们的医学网页上，你能够找到象什么是硬皮病？
On our main Medical page you can find links such as What is Scleroderma?
带状硬皮病累及头部时，有时被称为剑伤性硬皮病。
When linear scleroderma affects the head it is sometimes referred to as scleroderma en coup DE sabre.
目的探讨血小板衍生生长因子在硬皮病发病中的作用。
Objective To investigate the role of platelet-derived growth factor receptor in the development of scleroderma fibrosis.
自身免疫性：如红斑狼疮、类风湿关节炎、硬皮病等。
Autoimmune: such as lupus erythematosus, rheumatoid arthritis, scleroderma, and other.
目的观察VEGF对硬皮病小鼠模型毛发生长的作用。
Objective To study the effect of VEGF on the hair growth in mice with scleroderma.
目的提高对系统性硬皮病患者的手部X线表现的认识。
Objective To improve recognition on X ray appearance of hands of patients with systemic sclerosis (SSc).
微血管病变是硬皮病大部分临床表现及并发症的病理基础。
The microvascular modification is pathologic base of most clinical manifestation and complication of scleroderma.
很遗憾的是，至今为止还没有有效的治疗方法来治愈硬皮病。
Unfortunately, there is no proven treatment or cure for any form of scleroderma.
目的：探讨骨桥蛋白在硬皮病患者局部皮损表达和分布情况。
Objective: To explore the expression and distribution of osteopontin in local lesions of scleroderma patients.
这些都表明硬皮病患者肺间质纤维化的程度较治疗前明显好转。
All of this shows that scleroderma patients with pulmonary fibrosis than before treatment significantly improved.
结论VEGF对硬皮病小鼠模型毛囊的再生有明显的促进作用。
Conclusion VEGF can significantly promote the growth and regeneration of the hair follicles in the mice with scleroderma.
系统性硬化(硬皮病)病人食管蠕动障碍，因为黏膜下层纤维化。
Esophageal motility problems can occur in patients with progressive systemic sclerosis (scleroderma) because the submucosa becomes fibrotic.
对105例系统性硬皮病患者的一般情况、临床表现作了详细分析。
The clinical and laboratory data of 105 patients with systemic scleroderma (SSC) were analysed.
目的探讨以络病理论为指导辨证分型治疗系统性硬皮病的临床疗效。
Objective To discuss clinical curative effect of treatment for systemic scleroderma typed under guidance of the theory of collateral disease.
这些都是常用的治疗条件，如硬皮病可导致广泛的疤痕和硬化的皮肤。
These are often used to treat conditions such as scleroderma that can cause extensive scarring and hardening of the skin.
硬皮病是一种渐进性疾病，可累及全身任何器官，引起器官的纤维化。
Scleroderma is a progressive disease resulting in fibrosis of any organ system.
目的研究硬皮病成纤维细胞整合素表达对成纤维细胞合成原胶原的影响。
Objective Investigation of the effect of integrin on fibroblasts from scleroderma in the production of procollagen.
我们的目标是更好地管理作为一个多光谱，硬皮病，慢性疾病将得以实现。
The goal is that better management of scleroderma as a multi-spectrum, chronic disease will be achieved.
该病和硬皮病的临床表现很相似，都是以局限性皮肤硬化为主要皮损表现。
Its primary clinical manifestation is localized sclerosis of the skin, which is very similar to scleroderma.
肺间质纤维化最终所引起的呼吸循环衰竭是硬皮病患者的主要致死因素之一。
Pulmonary fibrosis caused by the end of the respiratory and circulatory failure in patients with scleroderma is the main factor of death.
该药能使导致肺纤维化的炎症得以减轻，在过去10年里被应用于硬皮病患者。
The drug decreases the inflammation that causes pulmonary fibrosis and has been used on scleroderma patients for the last 10 years.
硬皮病其他常见的影像学表现包括：肺纤维化、消化道蠕动异常（最常见于食管）。
Other common radiologic findings in scleroderma include pulmonary fibrosis and dilation and dysmotility of the gastrointestinal tract (most commonly affecting the esophagus).
硬皮病其他常见的影像学表现包括：肺纤维化、消化道蠕动异常（最常见于食管）。
Other common radiologic findings in scleroderma include pulmonary fibrosis and dilation and dysmotility of the gastrointestinal tract (most commonly affecting the esophagus).
应用推荐